SUVEN LIFE SCIENCES
Quarterly Results Analysis [Dec2025]
SUVEN LIFE SCIENCES Quarterly Results
| Consolidated | Dec2025 UnAudited |
Sep2025 Audited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 Audited |
Jun2024 UnAudited |
Mar2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹3 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹2 Cr |
| Expenses | ₹106 Cr | ₹81 Cr | ₹53 Cr | ₹45 Cr | ₹41 Cr | ₹55 Cr | ₹32 Cr | ₹33 Cr |
| Operating Income | ₹-103 Cr | ₹-80 Cr | ₹-51 Cr | ₹-44 Cr | ₹-39 Cr | ₹-52 Cr | ₹-31 Cr | ₹-30 Cr |
| Other Income | ₹3 Cr | ₹4 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
| Profit Before Tax | ₹-102 Cr | ₹-77 Cr | ₹-52 Cr | ₹-44 Cr | ₹-39 Cr | ₹-50 Cr | ₹-28 Cr | ₹-28 Cr |
| Profit After Tax | ₹-102 Cr | ₹-77 Cr | ₹-52 Cr | ₹-44 Cr | ₹-39 Cr | ₹-50 Cr | ₹-28 Cr | ₹-27 Cr |
| EPS | ₹-4.48 | ₹-3.40 | ₹-2.36 | ₹-2.02 | ₹-1.79 | ₹-2.28 | ₹-1.29 | ₹-1.22 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SUVEN LIFE SCIENCES | -4.3% | -19.7% | 8% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.8% | -7.5% | -12.2% |
| DIVIS LABORATORIES | -0.6% | -5.5% | 6.1% |
| CIPLA | -3.7% | -11.7% | -8.5% |
| TORRENT PHARMACEUTICALS | -2.5% | 3.5% | 21.1% |
| DR REDDYS LABORATORIES | -0.7% | -4.7% | -5.1% |
| MANKIND PHARMA | -2.1% | -3.7% | -19.6% |
| ZYDUS LIFESCIENCES | 0.6% | -1.5% | -9.3% |
| LUPIN | -1.5% | 2.5% | -1.3% |
SUVEN LIFE SCIENCES Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 205.66 % |
| Y-o-Y | 74.47 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹3 Cr | 205.66 | |
| Sep2025 | ₹1 Cr | -50.78 | |
| Jun2025 | ₹2 Cr | 27.27 | |
| Mar2025 | ₹1 Cr | -8.88 | |
| Dec2024 | ₹2 Cr | -37.43 | |
| Sep2024 | ₹3 Cr | 155.77 | |
| Jun2024 | ₹1 Cr | -57.82 | |
| Mar2024 | ₹2 Cr | - | |
SUVEN LIFE SCIENCES Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹-103 Cr | Negative | |
| Sep2025 | ₹-80 Cr | Negative | |
| Jun2025 | ₹-51 Cr | Negative | |
| Mar2025 | ₹-44 Cr | Negative | |
| Dec2024 | ₹-39 Cr | Negative | |
| Sep2024 | ₹-52 Cr | Negative | |
| Jun2024 | ₹-31 Cr | Negative | |
| Mar2024 | ₹-30 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | -3679.25% | Negative | |
| Sep2025 | -8680.2% | Negative | |
| Jun2025 | -2718.16% | Negative | |
| Mar2025 | -2987.12% | Negative | |
| Dec2024 | -2435.16% | Negative | |
| Sep2024 | -2029.07% | Negative | |
| Jun2024 | -3035.69% | Negative | |
| Mar2024 | -1269.94% | - | |
SUVEN LIFE SCIENCES Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹-102 Cr | Negative | |
| Sep2025 | ₹-77 Cr | Negative | |
| Jun2025 | ₹-52 Cr | Negative | |
| Mar2025 | ₹-44 Cr | Negative | |
| Dec2024 | ₹-39 Cr | Negative | |
| Sep2024 | ₹-50 Cr | Negative | |
| Jun2024 | ₹-28 Cr | Negative | |
| Mar2024 | ₹-27 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | -3628.41 % | Negative | |
| Sep2025 | -8412.4 % | Negative | |
| Jun2025 | -2759.29 % | Negative | |
| Mar2025 | -2995.57 % | Negative | |
| Dec2024 | -2429.69 % | Negative | |
| Sep2024 | -1929.38 % | Negative | |
| Jun2024 | -2787.28 % | Negative | |
| Mar2024 | -1112.83 % | - | |
SUVEN LIFE SCIENCES Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹-4.48 | Negative | |
| Sep2025 | ₹-3.4 | Negative | |
| Jun2025 | ₹-2.36 | Negative | |
| Mar2025 | ₹-2.02 | Negative | |
| Dec2024 | ₹-1.79 | Negative | |
| Sep2024 | ₹-2.28 | Negative | |
| Jun2024 | ₹-1.29 | Negative | |
| Mar2024 | ₹-1.22 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD